UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
VINC holding history
Vincerx Pharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VINC overviewAll 13F holders of VINCFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −142−100.0% | Sold out | Holders |
| Q1 2025 | 142 | $75 | <0.1% | −4,497−96.9% | ReducedConverted for a 1-for-20 split | Holders |
| Q4 2024 | 92,779 | $24.4K | <0.1% | +92,541+38,882.8% | Added | Holders |
| Q3 2024 | 238 | $171 | <0.1% | +237+23,700.0% | Added | Holders |
| Q2 2024 | 1 | $1 | <0.1% | −2,497−100.0% | Reduced | Holders |
| Q1 2024 | 2,498 | $12.6K | <0.1% | −451−15.3% | Reduced | Holders |
| Q4 2023 | 2,949 | $3.48K | <0.1% | −2,787−48.6% | Reduced | Holders |
| Q3 2023 | 5,736 | $5.79K | <0.1% | +5,736 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −1,567−100.0% | Sold out | Holders |
| Q3 2022 | 1,567 | $2.00K | <0.1% | +1,567 | New | Holders |